Arsenault Kaitlyn Melanie
- SEC CIK
- 0001877242
No open-market purchases or sales filed in the past year.
Current role at each company
- SKYE Skye Bioscience, Inc.Chief Financial Officeras of Feb 9, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Arsenault Kaitlyn Melanie as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2025 (view filing) | Nov 15-18, 2024 | 105 days | Arsenault Kaitlyn MelanieChief Financial Officer | SSale | −43.2K | $4.99 | −$215.8K | −20.5%167.5K after | Amended2 lots |